Related Experiment Video
Updated: Nov 30, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Relationship between Bell's Palsy and Previous Statin Use: A Case/Non-Case Study
So Young Kim1, Jee Hye Wee2, Chanyang Min3,4
1Department of Otorhinolaryngology-Head & Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.
This study found no link between prior statin use and Bell
Area of Science:
- Epidemiology
- Neurology
- Pharmacology
Background:
- Bell's palsy is a common neurological disorder affecting facial nerves.
- Statins are widely prescribed cholesterol-lowering drugs.
- The potential association between statin use and Bell's palsy requires investigation.
Purpose of the Study:
- To investigate the relationship between previous statin use and the incidence of Bell's palsy.
- To analyze statin prescription patterns in relation to Bell's palsy onset.
- To explore potential confounding factors in this association.
Main Methods:
- Retrospective cohort study using Korean National Health Insurance Service data (2002-2015).
- Matched case-control analysis comparing Bell's palsy patients (n=3203) with controls (n=12,812).
- Conditional logistic regression analysis of statin use days in the 2 years preceding Bell's palsy onset, with subgroup analyses.
Main Results:
- The Bell's palsy group showed higher previous statin use (84.6 days vs. 74.4 days, p=0.009).
- A crude association between statin use and Bell's palsy was observed (OR 1.03-1.19, p=0.006).
- This association disappeared after adjusting for covariates, with no subgroup showing increased odds.
Conclusions:
- No significant association was found between previous statin use and Bell's palsy in Korean adults aged 40 and above.
- Adjusting for confounding factors negated the initial observed crude association.
- Further research may be warranted to explore other potential risk factors for Bell's palsy.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Peripheral Artery Disease I: Introduction
Atherosclerosis IV: Nursing Management